{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T21:56:02Z","timestamp":1784152562080,"version":"3.55.0"},"publisher-location":"Cham","reference-count":46,"publisher":"Springer Nature Switzerland","isbn-type":[{"value":"9783031871665","type":"print"},{"value":"9783031871672","type":"electronic"}],"license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024]]},"DOI":"10.1007\/82_2024_266","type":"book-chapter","created":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T14:04:46Z","timestamp":1716300286000},"page":"173-184","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Blood Banking Capacity in Low-and Middle-Income Countries: Covid-19 Convalescent Plasma in Context"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8181-9517","authenticated-orcid":false,"given":"Evan M.","family":"Bloch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,22]]},"reference":[{"key":"266_CR1","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1111\/trf.16262","volume":"61","author":"Y Ahmad","year":"2021","unstructured":"Ahmad Y, Heroes AS, Hume HA, Farouk M, Owusu-Ofori A, Gehrie EA, Goel R, Ness PM, Tobian AAR, Bloch EM (2021) Bacterial contamination of blood products in Africa. Transfusion 61:767\u2013780","journal-title":"Transfusion"},{"key":"266_CR2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001309","volume":"9","author":"F Ala","year":"2012","unstructured":"Ala F, Allain JP, Bates I, Boukef K, Boulton F, Brandful J, Dax EM, El Ekiaby M, Farrugia A, Gorlin J, Hassall O, Lee H, Loua A, Maitland K, Mbanya D, Mukhtar Z, Murphy W, Opare-Sem O, Owusu-Ofori S, Reesink H, Roberts D, Torres O, Totoe G, Ullum H, Wendel S (2012) External financial aid to blood transfusion services in sub-Saharan Africa: a need for reflection. PLoS Med 9:e1001309","journal-title":"PLoS Med"},{"key":"266_CR3","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/j.1751-2824.2010.01423.x","volume":"5","author":"J-P Allain","year":"2010","unstructured":"Allain J-P (2010) Volunteer safer than replacement donor blood: a myth revealed by evidence. ISBT Sci Ser 5:169\u2013175","journal-title":"ISBT Sci Ser"},{"key":"266_CR4","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1111\/j.1365-2141.2011.08708.x","volume":"154","author":"JP Allain","year":"2011","unstructured":"Allain JP (2011) Moving on from voluntary non-remunerated donors: who is the best blood donor? Br J Haematol 154:763\u2013769","journal-title":"Br J Haematol"},{"key":"266_CR5","doi-asserted-by":"publisher","first-page":"5","DOI":"10.4103\/0973-6247.164270","volume":"10","author":"JP Allain","year":"2016","unstructured":"Allain JP, Sibinga CT (2016) Family donors are critical and legitimate in developing countries. Asian J Transfus Sci 10:5\u201311","journal-title":"Asian J Transfus Sci"},{"key":"266_CR6","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1016\/S0140-6736(16)00581-X","volume":"387","author":"JP Allain","year":"2016","unstructured":"Allain JP, Owusu-Ofori AK, Assennato SM, Marschner S, Goodrich RP, Owusu-Ofori S (2016) Effect of Plasmodium inactivation in whole blood on the incidence of blood transfusion-transmitted malaria in endemic regions: the African Investigation of the Mirasol System (AIMS) randomised controlled trial. Lancet 387:1753\u20131761","journal-title":"Lancet"},{"key":"266_CR7","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1111\/trf.16798","volume":"62","author":"LS Barnes","year":"2022","unstructured":"Barnes LS, Al-Riyami AZ, Ipe TS, Bloch EM, Sibinga CS, Eichbaum QG (2022) COVID-19 and the impact on blood availability and transfusion practices in low- and middle-income countries. Transfusion 62:336\u2013345","journal-title":"Transfusion"},{"key":"266_CR8","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1111\/j.1471-0528.2008.01866.x","volume":"115","author":"I Bates","year":"2008","unstructured":"Bates I, Chapotera GK, McKew S, van den Broek N (2008) Maternal mortality in sub-Saharan Africa: the contribution of ineffective blood transfusion services. BJOG 115:1331\u20131339","journal-title":"BJOG"},{"key":"266_CR9","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1111\/trf.15815","volume":"60","author":"EM Bloch","year":"2020","unstructured":"Bloch EM, Kipiani E, Shadaker S, Alkhazashvili M, Gvinjilia L, Kuchuloria T, Chitadze N, Keating SM, Gamkrelidze A, Turdziladze A, Getia V, Nasrullah M, Averhoff F, Izoria M, Skaggs B (2020a) Blood transfusion safety in the country of Georgia: collateral benefit from a national hepatitis C elimination program. Transfusion 60:1243\u20131252","journal-title":"Transfusion"},{"key":"266_CR10","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.1172\/JCI138745","volume":"130","author":"EM Bloch","year":"2020","unstructured":"Bloch EM, Shoham S, Casadevall A, Sachais BS, Shaz B, Winters JL, van Buskirk C, Grossman BJ, Joyner M, Henderson JP, Pekosz A, Lau B, Wesolowski A, Katz L, Shan H, Auwaerter PG, Thomas D, Sullivan DJ, Paneth N, Gehrie E, Spitalnik S, Hod EA, Pollack L, Nicholson WT, Pirofski LA, Bailey JA, Tobian AA (2020b) Deployment of convalescent plasma for the prevention and treatment of COVID-19. J Clin Invest 130:2757\u20132765","journal-title":"J Clin Invest"},{"key":"266_CR11","doi-asserted-by":"publisher","first-page":"482","DOI":"10.7326\/M20-0203","volume":"173","author":"EM Bloch","year":"2020","unstructured":"Bloch EM, Gehrie EA, Ness PM, Sugarman J, Tobian A (2020c) Blood transfusion safety in low-resourced countries: aspiring to a higher standard. Ann Intern Med 173:482\u2013483","journal-title":"Ann Intern Med"},{"key":"266_CR12","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/vox.12970","volume":"116","author":"EM Bloch","year":"2021","unstructured":"Bloch EM, Goel R, Wendel S, Burnouf T, Al-Riyami AZ, Ang AL, DeAngelis V, Dumont LJ, Land K, Lee CK, Oreh A, Patidar G, Spitalnik SL, Vermeulen M, Hindawi S, Van den Berg K, Tiberghien P, Vrielink H, Young P, Devine D, So-Osman C (2021b) Guidance for the procurement of COVID-19 convalescent plasma: differences between high- and low-middle-income countries. Vox Sang 116:18\u201335","journal-title":"Vox Sang"},{"key":"266_CR13","doi-asserted-by":"crossref","unstructured":"Bloch EM, Shah A, Kaidarova Z, Laperche S, Lefrere JJ, van Hasselt J, Zacharias P, Murphy EL, Anglophone Africa Transfusion Research G (2014) A pilot external quality assurance study of transfusion screening for HIV, HCV and HBsAG in 12 African countries. Vox Sang 107:333\u2013342","DOI":"10.1111\/vox.12182"},{"key":"266_CR14","doi-asserted-by":"crossref","unstructured":"Bloch EM, Goel R, Montemayor C, Cohn C, Tobian AAR (2021a) Promoting access to COVID-19 convalescent plasma in low- and middle-income countries. Transfus Apheresis Sci Off J World Apheresis Assoc Off J Eur Soc Haemapheresis 60:102957","DOI":"10.1016\/j.transci.2020.102957"},{"key":"266_CR15","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1182\/blood-2018-11-833996","volume":"133","author":"MP Busch","year":"2019","unstructured":"Busch MP, Bloch EM, Kleinman S (2019) Prevention of transfusion-transmitted infections. Blood 133:1854\u20131864","journal-title":"Blood"},{"key":"266_CR16","doi-asserted-by":"crossref","unstructured":"Carson JL, Grossman BJ, Kleinman S, Tinmouth AT, Marques MB, Fung MK, Holcomb JB, Illoh O, Kaplan LJ, Katz LM, Rao SV, Roback JD, Shander A, Tobian AA, Weinstein R, Swinton McLaughlin LG, Djulbegovic B (2012) Clinical transfusion medicine committee of the A. Red blood cell transfusion: a clinical practice guideline from the AABB*. Ann Intern Med 157:49\u201358","DOI":"10.7326\/0003-4819-157-1-201206190-00429"},{"key":"266_CR17","doi-asserted-by":"publisher","first-page":"115","DOI":"10.15585\/mmwr.mm6505a4","volume":"65","author":"MS Chevalier","year":"2016","unstructured":"Chevalier MS, Kuehnert M, Basavaraju SV, Bjork A, Pitman JP (2016) Progress toward strengthening national blood transfusion services\u201414 Countries, 2011\u20132014. MMWR Morb Mortal Wkly Rep 65:115\u2013119","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"266_CR18","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/S2213-2600(22)00050-9","volume":"10","author":"D Focosi","year":"2022","unstructured":"Focosi D, Casadevall A (2022) Convalescent plasma in outpatients with COVID-19. Lancet Respir Med 10:226\u2013228","journal-title":"Lancet Respir Med"},{"key":"266_CR19","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.tracli.2021.02.005","volume":"28","author":"D Focosi","year":"2021","unstructured":"Focosi D, Franchini M (2021) Impact of pathogen-reduction technologies on COVID-19 convalescent plasma potency. Transfus Clin Biol 28:132\u2013134","journal-title":"Transfus Clin Biol"},{"key":"266_CR20","doi-asserted-by":"publisher","DOI":"10.1128\/cmr.00200-21","volume":"35","author":"D Focosi","year":"2022","unstructured":"Focosi D, Franchini M, Pirofski LA, Burnouf T, Paneth N, Joyner MJ, Casadevall A (2022) COVID-19 convalescent plasma and clinical trials: understanding conflicting outcomes. Clin Microbiol Rev 35:e0020021","journal-title":"Clin Microbiol Rev"},{"key":"266_CR21","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1056\/NEJM196408132710702","volume":"271","author":"GF Grady","year":"1964","unstructured":"Grady GF, Chalmers TC (1964) Risk of Post-Transfusion Viral Hepatitis. N Engl J Med 271:337\u2013342","journal-title":"N Engl J Med"},{"key":"266_CR22","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1111\/trf.12968","volume":"55","author":"RL Haspel","year":"2015","unstructured":"Haspel RL, Lin Y, Mallick R, Tinmouth A, Cid J, Eichler H, Lozano M, van de Watering L, Fisher PB, Ali A, Parks E, Investigators B-T (2015) Internal medicine resident knowledge of transfusion medicine: results from the BEST-TEST international education needs assessment. Transfusion 55:1355\u20131361","journal-title":"Transfusion"},{"key":"266_CR23","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/trf.14374","volume":"58","author":"L Ifland","year":"2018","unstructured":"Ifland L, Bloch EM, Pitman JP (2018) Funding blood safety in the 21st century. Transfusion 58:105\u2013112","journal-title":"Transfusion"},{"key":"266_CR24","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1111\/j.1537-2995.2009.002402.x","volume":"50","author":"S Jayaraman","year":"2010","unstructured":"Jayaraman S, Chalabi Z, Perel P, Guerriero C, Roberts I (2010) The risk of transfusion-transmitted infections in sub-Saharan Africa. Transfusion 50:433\u2013442","journal-title":"Transfusion"},{"key":"266_CR25","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1111\/vox.13056","volume":"116","author":"AI Kostin","year":"2021","unstructured":"Kostin AI, Lundgren MN, Bulanov AY, Ladygina EA, Chirkova KS, Gintsburg AL, Logunov DY, Dolzhikova IV, Shcheblyakov DV, Borovkova NV, Godkov MA, Bazhenov AI, Shustov VV, Bogdanova AS, Kamalova AR, Ganchin VV, Dombrovskiy EA, Volkov SE, Drozdova NE, Petrikov SS (2021) Impact of pathogen reduction methods on immunological properties of the COVID-19 convalescent plasma. Vox Sang 116:665\u2013672","journal-title":"Vox Sang"},{"key":"266_CR26","doi-asserted-by":"crossref","unstructured":"Laperche S (2013) Francophone African group for research in blood T. Multinational assessment of blood-borne virus testing and transfusion safety on the African continent. Transfusion 53:816\u2013826","DOI":"10.1111\/j.1537-2995.2012.03797.x"},{"key":"266_CR27","first-page":"206","volume":"20","author":"L Larrea","year":"2022","unstructured":"Larrea L, Castro E, Navarro L, Vera B, Franc\u00e9s-G\u00f3mez C, S\u00e1nchez-Sendra B, Gim\u00e9nez \u00c1, Castell\u00f3 E, Collado M, Vay\u00e1 MJ, Mirabet V, Callao V, Ortiz-de-Salazar MI, Roig R, Geller R, Arbona C (2022) Preservation of anti-SARS-CoV-2 neutralising antibodies in convalescent plasma after pathogen reduction with methylene blue and visible light. Blood Transfus 20:206\u2013212","journal-title":"Blood Transfus"},{"key":"266_CR28","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1111\/j.1537-2995.2010.02886.x","volume":"51","author":"JJ Lefrere","year":"2011","unstructured":"Lefrere JJ, Dahourouh H, Dokekias AE, Kouao MD, Diarra A, Diop S, Tapko JB, Murphy EL, Laperche S, Pillonel J (2011) Estimate of the residual risk of transfusion-transmitted human immunodeficiency virus infection in sub-Saharan Africa: a multinational collaborative study. Transfusion 51:486\u2013492","journal-title":"Transfusion"},{"key":"266_CR29","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.transci.2014.10.015","volume":"51","author":"VJ Louw","year":"2014","unstructured":"Louw VJ (2014) Transfusion education and practice in South Africa. Transfus Apher Sci 51:6\u20137","journal-title":"Transfus Apher Sci"},{"key":"266_CR30","doi-asserted-by":"publisher","first-page":"3121","DOI":"10.1111\/trf.13816","volume":"56","author":"MM Morar","year":"2016","unstructured":"Morar MM, Pitman JP, McFarland W, Bloch EM (2016) The contribution of unsafe blood transfusion to human immunodeficiency virus incidence in sub-Saharan Africa: reexamination of the 5% to 10% convention. Transfusion 56:3121\u20133132","journal-title":"Transfusion"},{"key":"266_CR31","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1111\/j.1423-0410.2012.1661.x","volume":"104","author":"S Panzer","year":"2013","unstructured":"Panzer S, Engelbrecht S, Cole-Sinclair MF, Wood EM, Wendel S, Biagini S, Zhu Z, Lefr\u00e8re JJ, Andreu G, Zunino T, Cabaud JJ, Rouger P, Garraud O, Janetzko K, M\u00fcller-Steinhardt M, van der Burg P, Brand A, Agarwal P, Triyono T, Gharehbaghian A, Manny N, Zelig O, Takeshita A, Yonemura Y, Fujihara H, Nollet KE, Ohto H, Han KS, Nadarajan VS, Berlin G, Sandler SG, Strauss RG, Reesink HW (2013) Education in transfusion medicine for medical students and doctors. Vox Sang 104:250\u2013272","journal-title":"Vox Sang"},{"key":"266_CR32","doi-asserted-by":"crossref","unstructured":"Patidar GK, Thachil J, Dhiman Y, Oreh A, Vrielink H, van den Berg K, Grubovic Rastvorceva RM, So-Osman C, Al-Riyami AZ (2022) Management of blood transfusion services in low-resource countries. Vox Sang 117:1375\u20131383","DOI":"10.1111\/vox.13373"},{"key":"266_CR33","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1111\/vox.12327","volume":"110","author":"C Prugger","year":"2016","unstructured":"Prugger C, Laperche S, Murphy EL, Bloch EM, Kaidarova Z, Tafflet M, Lefrere JJ, Jouven X (2016) Screening for transfusion transmissible infections using rapid diagnostic tests in Africa: a potential hazard to blood safety? Vox Sang 110:196\u2013198","journal-title":"Vox Sang"},{"key":"266_CR34","doi-asserted-by":"crossref","unstructured":"Rambiritch V, Vermeulen M, Bell H, Knox P, Nedelcu E, Al-Riyami AZ, Callum J, van den Berg K, Forum obotESotAGT (2021) Transfusion medicine and blood banking education and training for blood establishment laboratory staff: a review of selected countries in Africa. Transfusion 61:1955\u20131965","DOI":"10.1111\/trf.16372"},{"key":"266_CR35","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1159\/000514485","volume":"48","author":"J Raster","year":"2021","unstructured":"Raster J, Zimmermann K, Wesche J, Aurich K, Greinacher A, Selleng K (2021) Effect of methylene blue pathogen inactivation on the integrity of immunoglobulin M and G. Transfus Med Hemother 48:148\u2013153","journal-title":"Transfus Med Hemother"},{"key":"266_CR36","doi-asserted-by":"publisher","first-page":"e606","DOI":"10.1016\/S2352-3026(19)30200-5","volume":"6","author":"N Roberts","year":"2019","unstructured":"Roberts N, James S, Delaney M, Fitzmaurice C (2019) The global need and availability of blood products: a modelling study. Lancet Haematol 6:e606\u2013e615","journal-title":"Lancet Haematol"},{"key":"266_CR37","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1111\/trf.16250","volume":"61","author":"WR Steele","year":"2021","unstructured":"Steele WR, Dodd RY, Notari EP, Haynes J, Anderson SA, Williams AE, Reik R, Kessler D, Custer B, Stramer SL (2021) HIV, HCV, and HBV incidence and residual risk in US blood donors before and after implementation of the 12-month deferral policy for men who have sex with men. Transfusion 61:839\u2013850","journal-title":"Transfusion"},{"key":"266_CR38","doi-asserted-by":"crossref","unstructured":"Tagny CT, Murphy EL, Lefr\u00e8re J-J, Network ObotFABTR (2013) The francophone Africa blood transfusion research network: a five-year report (2007\u20132012). Transfus Med 23: 442\u2013424","DOI":"10.1111\/tme.12076"},{"key":"266_CR39","unstructured":"Tapko J, Mainuka P, Diarra-Nama AJ (2006) Status of blood safety in the WHO African region: report of the 2006 survey. http:\/\/www.afro.who.int\/en\/divisions-a-programmes\/dsd\/health-technologies-a-laboratories.html. WHO Regional Office for Africa, Brazzaville, Republic of Congo"},{"key":"266_CR40","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/vox.12620","volume":"113","author":"AD Ware","year":"2018","unstructured":"Ware AD, Jacquot C, Tobian AAR, Gehrie EA, Ness PM, Bloch EM (2018) Pathogen reduction and blood transfusion safety in Africa: strengths, limitations and challenges of implementation in low-resource settings. Vox Sang 113:3\u201312","journal-title":"Vox Sang"},{"key":"266_CR41","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1111\/trf.14949","volume":"59","author":"A Weimer","year":"2019","unstructured":"Weimer A, Tagny CT, Tapko JB, Gouws C, Tobian AAR, Ness PM, Bloch EM (2019) Blood transfusion safety in sub-Saharan Africa: a literature review of changes and challenges in the 21st century. Transfusion 59:412\u2013427","journal-title":"Transfusion"},{"key":"266_CR42","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1016\/S1473-3099(22)00417-0","volume":"22","author":"CR Wells","year":"2022","unstructured":"Wells CR, Galvani AP (2022) The global impact of disproportionate vaccination coverage on COVID-19 mortality. Lancet Infect Dis 22:1254\u20131255","journal-title":"Lancet Infect Dis"},{"key":"266_CR43","unstructured":"WHO (2013) Guidelines on management of blood and blood components as essential medicines, Annex 3, TRS No 1004 [monograph on the internet]. Available from: https:\/\/www.who.int\/publications\/m\/item\/blood-and-blood-components-as-essential-medicines-annex-3-trs-no-1004"},{"key":"266_CR44","unstructured":"WHO (2022) WHO African region status report on blood availability, safety and quality Brazzaville, Republic of Congo: WHO Regional Office for Africa"},{"key":"266_CR45","unstructured":"WHO (2023) Blood safety and availability [monograph on the internet]. 2023. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/blood-safety-and-availability"},{"key":"266_CR46","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1016\/S0140-6736(18)30458-6","volume":"391","author":"ML Wilson","year":"2018","unstructured":"Wilson ML, Fleming KA, Kuti MA, Looi LM, Lago N, Ru K (2018) Access to pathology and laboratory medicine services: a crucial gap. The Lancet 391:1927\u20131938","journal-title":"The Lancet"}],"container-title":["Current Topics in Microbiology and Immunology","Convalescent Plasma and Other Antibody Therapies for Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/82_2024_266","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T09:54:36Z","timestamp":1784109276000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/82_2024_266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"ISBN":["9783031871665","9783031871672"],"references-count":46,"URL":"https:\/\/doi.org\/10.1007\/82_2024_266","relation":{},"ISSN":["0070-217X","2196-9965"],"issn-type":[{"value":"0070-217X","type":"print"},{"value":"2196-9965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"22 May 2024","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"The author was supported in part by the National Heart Lung and Blood Institute (1K23HL15182) and is a co-investigator on a US government funded clinical trial evaluating Mirasol Pathogen Reduction Technology. The author reports personal fees and non-financial support from Grifols, Abbott, UptoDate, Tegus, and Health Advances outside of the submitted work.The author is a member of the U.S. Food and Drug Administration (FDA) Blood Products Advisory Committee. Any views or opinions expressed in this chapter are Dr. Bloch\u2019s and are based on his own scientific expertise and professional judgment; they do not necessarily represent the views of the Blood Products Advisory Committee or the formal position of the FDA and also do not bind or otherwise obligate or commit either the Advisory Committee or the FDA to the views expressed.","order":1,"name":"Ethics","label":"Declarations and Disclosures","group":{"name":"EthicsHeading","label":"Ethics"}}]}}